Literature DB >> 28509354

Single disease entity for both chromosomal instable subtype gastric adenocarcinoma and esophageal adenocarcinoma.

Qin Huang1,2,3.   

Abstract

Gastric cardiac carcinoma (GCC) was and is considered as a part of esophageal adenocarcinoma (EAC) and staged with the rules for EAC. This may change. Recent comprehensive integrated genomic investigations on gastric and esophageal carcinomas discovered similar chromosomal instability profiles in these two groups of carcinomas with a gradual increasing gradient from the lowest percentage in the distal gastric antrum to a high level in the proximal gastric cardia, and to the peak of almost 100% in EAC. Therefore, most GCCs and EAC share similar chromosomal instable features of gastric carcinoma and should be grouped as a single disease entity because EAC may be the proximal extension of chromosomal instable GCCs. This breakthrough discovery in genomic characteristics of GCC and EAC would dramatically change the strategy on how patients should be appropriately managed clinically and also greatly help future investigation on detailed molecular pathogenetic mechanisms of GCC, leading to cure this fatal cancer.
© 2017 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  carcinoma; chromosomal instability; esophagus; gastric cardia; stomach

Mesh:

Year:  2017        PMID: 28509354     DOI: 10.1111/1751-2980.12484

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  2 in total

Review 1.  The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer.

Authors:  Ming Wei; Duo Shen; Sachin Mulmi Shrestha; Juan Liu; Junyi Zhang; Ying Yin
Journal:  Biomed Res Int       Date:  2018-02-27       Impact factor: 3.411

2.  Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.

Authors:  Ya-Zhen Zhu; Xi-Wen Liao; Wu Yin; Hai-Ming Wei
Journal:  Int J Gen Med       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.